Gregory Flesher
Chief Executive Officer at RENEO PHARMACEUTICALS, INC.
Net worth: 38 280 $ as of 2024-04-29
Gregory Flesher active positions
| Companies | Position | Start | End |
|---|---|---|---|
| RENEO PHARMACEUTICALS, INC. | Director/Board Member | 2020-12-08 | - |
| Chief Executive Officer | 2020-12-08 | - | |
| President | 2020-12-08 | - | |
| Reneo Pharma Ltd. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| President | - | - |
Career history of Gregory Flesher
Former positions of Gregory Flesher
| Companies | Position | Start | End |
|---|---|---|---|
| ADYNXX, INC. | Director/Board Member | 2019-07-21 | 2021-05-31 |
| ELEDON PHARMACEUTICALS, INC. | Director/Board Member | 2017-04-30 | 2020-09-03 |
| Chief Executive Officer | 2017-04-30 | 2020-09-03 | |
| President | 2017-04-30 | 2017-11-05 | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Director/Board Member | 2015-07-26 | 2017-04-30 |
| Chief Executive Officer | 2015-07-26 | 2017-04-30 | |
| AVANIR PHARMACEUTICALS INC | Corporate Officer/Principal | 2011-02-16 | 2014-12-31 |
| INTERMUNE INC | Sales & Marketing | 2001-12-31 | 2005-12-31 |
Training of Gregory Flesher
| Purdue University | Undergraduate Degree |
| The Indiana University School of Medicine | Undergraduate Degree |
Statistics
International
| United States | 9 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 5 |
| Chief Executive Officer | 4 |
| President | 3 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| ADYNXX, INC. | Health Technology |
| RENEO PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Health Technology |
| Reneo Pharma Ltd. |
- Stock Market
- Insiders
- Gregory Flesher
- Experience
